Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK21542 Injection for Postoperative Pain After Orthopedic Surgery (Phase III)
CTR20252826Phase 3Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Jul 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of hsk21542 in postoperative pain, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Jul 2025; status: completed.
02
Drugs
hsk21542
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20252826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252826.